Материалы

31.05.2017

Diagnostic Value of Presepsin in Neonatal Sepsis

Abstract:
Presepsin has recently been described as biomarker of sepsis. The aim of this study was to investigate the diagnostic accuracy of presepsin in diagnosing neonatal sepsis and discriminating sepsis from non-infectious systemic inflammatory response syndrome (SIRS).
The study included 70 full term neonates divided into three groups:
1) Sepsis group (22 patients with clinically suspected sepsis and positive blood cultures).
2) Non-infectious SIRS group (28 patients with clinically suspected sepsis and persistently negative blood cultures).
3) Control group (20 healthy neonates without any clinical signs of
infection).

Яндекс.Метрика